ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus

Trial Identifier:	D1843R00254
Sponsor:	AstraZeneca
Collaborator:	Brigham Women’s Health
NCTID::	NCT02910089
Start Date:	October 2016
Primary Completion Date:	December 2017
Study Completion Date:	December 2017
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, MA	Boston, MA, United States of America, 2115

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.